According to a Swedish study, CDKN2A positive families accounted for 11.5% of all melanoma families, and the positivity correlated with the number of affected individuals; in the positive families a median of six melanomas were diagnosed compared to two in mutation negative families [58]. The gene discussed is CDKN2A; the disease is melanoma.